Gut Microbiome and Endocrine Interactions

The gut microbiota acts as a metabolic and endocrine organ. It produces bioactive molecules that influence insulin sensitivity and inflammation. Dysbiosis contributes to obesity, diabetes, and autoimmune endocrine disorders. Microbiome-targeted probiotics and prebiotics are showing therapeutic promise. Understanding host-microbe cross-talk may lead to precision microbiome therapies. Integrating microbiome research into endocrinology enhances holistic metabolic care.

Exploratory Dimensions:

  • Microbial Metabolites and Hormone Regulation
  • Probiotic Therapies for Diabetes and Obesity
  • Gut-Brain-Endocrine Communication Pathways

    Related Conference of Gut Microbiome and Endocrine Interactions

    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    Gut Microbiome and Endocrine Interactions Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in